| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥4.77B | +182.1% |
| Gross profit | ¥0.93B | — |
| Operating income | ¥0.37B | — |
| Net income | ¥0.33B | — |
| Gross margin | 19.6% | Net margin 6.9% |
| Revenue Q/Q | +9.3% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥3.83B | 80.4% |
| R&D | ¥0.18B | 3.7% |
| SG&A | ¥0.22B | 4.7% |
| Tax & other | ¥0.04B | 0.8% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
美康生物 ・ 运达科技 ・ 鲍斯股份 ・ 金雷股份 ・ 双杰电气 ・ 康斯特 ・ 航天智造 ・ 全信股份 ・ 浩云科技 ・ 汉邦高科 ・ 创业慧康 ・ 山河药辅
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies